vs

Side-by-side financial comparison of i-80 Gold Corp. (IAUX) and NewAmsterdam Pharma Co N.V. (NAMS). Click either name above to swap in a different company.

i-80 Gold Corp. is the larger business by last-quarter revenue ($21.3M vs $19.1M, roughly 1.1× NewAmsterdam Pharma Co N.V.). NewAmsterdam Pharma Co N.V. runs the higher net margin — -90.7% vs -401.9%, a 311.2% gap on every dollar of revenue. NewAmsterdam Pharma Co N.V. produced more free cash flow last quarter ($-37.8M vs $-39.2M).

i-80 Gold Corp is a mineral exploration and development firm focused on gold and silver asset operations in Nevada, US. It advances high-potential mining projects, using responsible extraction practices to deliver precious metals to global industrial and investment markets.

Kite Pharma, Inc. is an American biotechnology company that develops cancer immunotherapy products with a primary focus on genetically engineered autologous CAR T cell therapy - a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009, and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017.

IAUX vs NAMS — Head-to-Head

Bigger by revenue
IAUX
IAUX
1.1× larger
IAUX
$21.3M
$19.1M
NAMS
Higher net margin
NAMS
NAMS
311.2% more per $
NAMS
-90.7%
-401.9%
IAUX
More free cash flow
NAMS
NAMS
$1.5M more FCF
NAMS
$-37.8M
$-39.2M
IAUX

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
IAUX
IAUX
NAMS
NAMS
Revenue
$21.3M
$19.1M
Net Profit
$-85.6M
$-17.4M
Gross Margin
22.0%
Operating Margin
-291.6%
-186.1%
Net Margin
-401.9%
-90.7%
Revenue YoY
740.1%
Net Profit YoY
55.5%
EPS (diluted)
$-0.10
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IAUX
IAUX
NAMS
NAMS
Q4 25
$21.3M
Q3 25
$32.0M
Q2 25
$27.8M
$19.1M
Q1 25
$14.0M
Q4 24
$12.8M
Q3 24
$11.5M
$29.1M
Q2 24
$7.2M
Q2 23
$8.6M
Net Profit
IAUX
IAUX
NAMS
NAMS
Q4 25
$-85.6M
Q3 25
$-41.9M
Q2 25
$-30.2M
$-17.4M
Q1 25
$-41.2M
Q4 24
$-92.2M
Q3 24
$-43.1M
$-16.6M
Q2 24
$-41.0M
Q2 23
$-42.0M
Gross Margin
IAUX
IAUX
NAMS
NAMS
Q4 25
22.0%
Q3 25
9.7%
Q2 25
2.9%
Q1 25
20.7%
Q4 24
Q3 24
-42.7%
Q2 24
-171.4%
Q2 23
Operating Margin
IAUX
IAUX
NAMS
NAMS
Q4 25
-291.6%
Q3 25
-86.7%
Q2 25
-67.4%
-186.1%
Q1 25
-112.3%
Q4 24
-338.5%
Q3 24
-210.0%
-85.9%
Q2 24
-435.2%
Q2 23
-461.8%
Net Margin
IAUX
IAUX
NAMS
NAMS
Q4 25
-401.9%
Q3 25
-130.8%
Q2 25
-108.5%
-90.7%
Q1 25
-293.3%
Q4 24
-721.7%
Q3 24
-374.5%
-57.2%
Q2 24
-570.8%
Q2 23
-486.9%
EPS (diluted)
IAUX
IAUX
NAMS
NAMS
Q4 25
$-0.10
Q3 25
$-0.05
Q2 25
$-0.05
$-0.15
Q1 25
$-0.10
Q4 24
$-0.91
Q3 24
$-0.11
$-0.18
Q2 24
$-0.11
Q2 23
$-0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IAUX
IAUX
NAMS
NAMS
Cash + ST InvestmentsLiquidity on hand
$63.2M
$739.2M
Total DebtLower is stronger
$174.7M
Stockholders' EquityBook value
$346.8M
$778.5M
Total Assets
$703.4M
$815.1M
Debt / EquityLower = less leverage
0.50×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IAUX
IAUX
NAMS
NAMS
Q4 25
$63.2M
Q3 25
$102.9M
Q2 25
$133.7M
$739.2M
Q1 25
$13.5M
Q4 24
$834.2M
Q3 24
$21.8M
$422.7M
Q2 24
$47.8M
Q2 23
Total Debt
IAUX
IAUX
NAMS
NAMS
Q4 25
$174.7M
Q3 25
$175.9M
Q2 25
$175.8M
Q1 25
$197.5M
Q4 24
Q3 24
Q2 24
Q2 23
Stockholders' Equity
IAUX
IAUX
NAMS
NAMS
Q4 25
$346.8M
Q3 25
$423.0M
Q2 25
$463.5M
$778.5M
Q1 25
$318.0M
Q4 24
$757.5M
Q3 24
$346.9M
$378.9M
Q2 24
$377.2M
Q2 23
$398.4M
Total Assets
IAUX
IAUX
NAMS
NAMS
Q4 25
$703.4M
Q3 25
$756.2M
Q2 25
$782.9M
$815.1M
Q1 25
$659.0M
Q4 24
$864.6M
Q3 24
$439.2M
Q2 24
Q2 23
Debt / Equity
IAUX
IAUX
NAMS
NAMS
Q4 25
0.50×
Q3 25
0.42×
Q2 25
0.38×
Q1 25
0.62×
Q4 24
Q3 24
Q2 24
Q2 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IAUX
IAUX
NAMS
NAMS
Operating Cash FlowLast quarter
$-34.3M
$-37.7M
Free Cash FlowOCF − Capex
$-39.2M
$-37.8M
FCF MarginFCF / Revenue
-184.3%
-197.2%
Capex IntensityCapex / Revenue
23.1%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-93.2M
$-119.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IAUX
IAUX
NAMS
NAMS
Q4 25
$-34.3M
Q3 25
$-15.2M
Q2 25
$-11.3M
$-37.7M
Q1 25
$-22.7M
Q4 24
$-37.5M
Q3 24
$-23.5M
$-12.5M
Q2 24
$-24.6M
Q2 23
$-31.9M
Free Cash Flow
IAUX
IAUX
NAMS
NAMS
Q4 25
$-39.2M
Q3 25
$-18.5M
Q2 25
$-12.4M
$-37.8M
Q1 25
$-23.1M
Q4 24
$-37.5M
Q3 24
$-23.8M
$-12.6M
Q2 24
$-25.1M
Q2 23
$-31.9M
FCF Margin
IAUX
IAUX
NAMS
NAMS
Q4 25
-184.3%
Q3 25
-57.8%
Q2 25
-44.7%
-197.2%
Q1 25
-164.1%
Q4 24
-293.5%
Q3 24
-206.7%
-43.2%
Q2 24
-349.1%
Q2 23
-369.3%
Capex Intensity
IAUX
IAUX
NAMS
NAMS
Q4 25
23.1%
Q3 25
10.2%
Q2 25
3.9%
0.5%
Q1 25
2.5%
Q4 24
0.0%
Q3 24
2.5%
0.3%
Q2 24
7.3%
Q2 23
0.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IAUX
IAUX

Granite Creek Mining Company$20.3M95%
Ruby Hill Mining Company LLC$991.0K5%
Lone Tree Minning Company$3.0K0%

NAMS
NAMS

Segment breakdown not available.

Related Comparisons